Todralazine 分子结构式
HCID5501

Todralazine

ethyl N-(phthalazin-1-ylamino)carbamate

C11H12N4O2232.24 g/molCAS 14679-73-3

IDENTITY

结构与身份

标准SMILES
CCOC(=O)NNc1nncc2ccccc12
InChIKey
WGZDBVOTUVNQFP-UHFFFAOYSA-N
分子式
C11H12N4O2
平均分子量
232.24 g/mol
单同位素质量
232.09602564

COMPUTED

结构计算性质

已同步
XLogP
1.7
极性表面积
76.1 Ų
氢键供体
2
氢键受体
5
可旋转键
4
重原子
17
形式电荷
0
复杂度
262

PROPERTIES

实验与物化性质

Collision Cross Section

151.8 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: TOXCAST; Source Identifier: DTXSID4044664];152.0 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: APCI+; Dataset: TOXCAST; Source Identifier: DTXSID4044664];158.8 Ų [M+Na]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: TOXCAST; Source Identifier: DTXSID4044664]

141.14 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];149.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];156.68 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];155.49 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

PHARMACOLOGY

药理信息

MeSH Pharmacological Classification

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

ALIASES

名称与别名

共 95 条
todralazine14679-73-3EcarazineEthyl 3-(1-phthalazinyl)carbazateCEPH FREE BASEWEN3K83YKDBT-621 FREE BASENSC-757868DTXSID0045048TodrazolineHydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, monohydrochlorideRefChem:190269DTXCID8025048TodralazinaTodralacinaCarboethoxyphthalazinohydrazine3-(1-Phthalazinyl)carbazic acid ethyl esterBT 621CARBAZIC ACID, 3-(1-PHTHALAZINYL)-, ETHYL ESTERCEPH

REACTIONS

相关反应

1
HRID 261776 反应方程式

uspto-grants-1979_05 · 10.6084/m9.figshare.5104873.v1 · US04152435

查看